目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.3. Competitive Insights

Chapter 3. U.S. Durable Medical Equipment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing prevalence of chronic diseases requiring long term care
3.4.1.2. Rapidly growing geriatric population
3.4.1.3. Increasing penetration of home healthcare services and staff
3.4.2. Market restraint analysis
3.4.2.1. High purchasing and maintenance cost
3.4.2.2. Lack of skilled professionals to handle this equipment
3.4.3. Industry challenge
3.4.3.1. Product recall
3.4.3.2. Rising competition
3.4.4. COVID - 19 impact on the industry
3.5. U.S. Durable Medical Equipment Market Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. U.S. Durable Medical Equipment Market: Product Estimates & Trend Analysis (Value and Volume)
4.1. Definitions and Scope
4.1.1. Personal Mobility Devices
4.1.1.1. Wheelchairs
4.1.1.2. Scooters
4.1.1.3. Walker & Rollators
4.1.1.4. Canes & Crutches
4.1.1.5. Door Openers
4.1.1.6. Others
4.1.2. Bathroom Safety Devices & Medical Furniture
4.1.2.1. Commodes & Toilets
4.1.2.2. Mattress & Bedding Devices
4.1.3. Monitoring & Therapeutic Devices
4.1.3.1. Blood Sugar Monitors
4.1.3.2. Continuous Passive Motion (CPM)
4.1.3.3. Infusion Pumps
4.1.3.4. Nebulizers
4.1.3.5. Oxygen Equipment
4.1.3.6. Continuous Positive Airway Pressure (CPAP)
4.1.3.7. Suction Pumps
4.1.3.8. Traction Equipment
4.1.3.9. Others
4.1.3.9.1. Insulin Pumps
4.1.3.9.2. Ostomy Bags & Accessories
4.1.3.9.3. Wound Care Products
4.1.3.9.4. Cardiology Devices
4.1.3.9.5. Vital Signs Monitor
4.1.3.9.6. Respiratory Supplies
4.1.3.9.7. Urinary Supplies
4.1.3.9.8. Diabetic Supplies
4.1.3.9.9. Incontinence Products
4.1.3.9.10. Orthopedic Braces & Support
4.1.3.9.11. Muscle Stimulators
4.1.3.9.12. Others
4.2. Segment Dashboard
4.3. The U.S. Durable Medical Equipment Market Share, 2021 & 2030
4.4. The U.S. Durable Medical Equipment Market by Product Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1. Personal Mobility Devices
4.5.1.1. Wheelchairs
4.5.1.1.1. Electric wheelchairs
4.5.1.1.2. Manual wheelchairs
4.5.1.2. Scooters
4.5.1.3. Walker & Rollators
4.5.1.4. Canes & Crutches
4.5.1.5. Door Openers
4.5.1.6. Others
4.5.2. Bathroom Safety Devices and Medical Furniture
4.5.2.1. Commodes & Toilets
4.5.2.2. Mattress & Bedding Devices
4.5.3. Monitoring and Therapeutic Devices
4.5.3.1. Blood Sugar Monitors
4.5.3.2. Continuous Passive Motion (CPM)
4.5.3.3. Infusion Pumps
4.5.3.4. Nebulizers
4.5.3.5. Oxygen Equipment
4.5.3.6. Continuous Positive Airway Pressure (CPAP)
4.5.3.7. Suction Pumps
4.5.3.8. Traction Equipment
4.5.3.9. Others
4.5.3.9.1. Insulin Pumps
4.5.3.9.2. Ostomy Bags & Accessories
4.5.3.9.3. Wound Care Products
4.5.3.9.4. Cardiology Devices
4.5.3.9.5. Vital Signs Monitor
4.5.3.9.6. Respiratory Supplies
4.5.3.9.7. Urinary Supplies
4.5.3.9.8. Diabetic Supplies
4.5.3.9.9. Incontinence Products
4.5.3.9.10. Orthopedic Braces & Support
4.5.3.9.11. Muscle Stimulators
4.5.3.9.12. Others

Chapter 5. Competitive Landscape
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.2.1. Innovators
5.3. Vendor Landscape
5.3.1. List Of Key Distributors and Channel Partners
5.3.2. Key Customers
5.3.3. Key Company Market Share Analysis, 2021
5.3.4. Invacare Corporation
5.3.4.1. Company overview
5.3.4.2. Financial performance
5.3.4.3. Product benchmarking
5.3.4.4. Strategic initiatives
5.3.5. Sunrise Medical
5.3.5.1. Company overview
5.3.5.2. Financial performance
5.3.5.3. Product benchmarking
5.3.5.4. Strategic initiatives
5.3.6. ArjoHuntleigh
5.3.6.1. Company overview
5.3.6.2. Financial performance
5.3.6.3. Product benchmarking
5.3.6.4. Strategic initiatives
5.3.7. Hill-Rom
5.3.7.1. Company overview
5.3.7.2. Financial performance
5.3.7.3. Product benchmarking
5.3.7.4. Strategic initiatives
5.3.8. Stryker
5.3.8.1. Company overview
5.3.8.2. Financial performance
5.3.8.3. Product benchmarking
5.3.8.4. Strategic initiatives
5.3.9. Medline Industries, Inc.
5.3.9.1. Company overview
5.3.9.2. Financial performance
5.3.9.3. Product benchmarking
5.3.9.4. Strategic initiatives
5.3.10. Medical Device Depot, Inc.
5.3.10.1. Company overview
5.3.10.2. Financial performance
5.3.10.3. Product benchmarking
5.3.10.4. Strategic initiatives
5.3.11. GF Health Products Inc.
5.3.11.1. Company overview
5.3.11.2. Financial performance
5.3.11.3. Product benchmarking
5.3.11.4. Strategic initiatives
5.3.12. Carex Health Brands
5.3.12.1. Company overview
5.3.12.2. Financial performance
5.3.12.3. Product benchmarking
5.3.12.4. Strategic initiatives
5.3.13. Baxter International, Inc.
5.3.13.1. Company overview
5.3.13.2. Financial performance
5.3.13.3. Product benchmarking
5.3.13.4. Strategic initiatives
5.3.14. Becton, Dickinson, and Company
5.3.14.1. Company overview
5.3.14.2. Financial performance
5.3.14.3. Product benchmarking
5.3.14.4. Strategic initiatives
5.3.15. Joerns Healthcare LLC
5.3.15.1. Company overview
5.3.15.2. Financial performance
5.3.15.3. Product benchmarking
5.3.15.4. Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Durable Medical Equipment Market, by Product, 2018 - 2030 (USD Million)
Table 4 U.S. Personal Mobility Devices Market, by Product, 2018 - 2030 (USD Million)
Table 5 U.S. Bathroom Safety Devices And Medical Furniture Market, by Product, 2018 - 2030 (USD Million)
Table 6 U.S. Monitoring and Therapeutic Devices Market, by Product, 2018 - 2030 (USD Million)
Table 7 U.S. Other Monitoring and Therapeutic Devices Market, by Product, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. DME market: Market snapshot
Fig. 9 U.S. DME market: Market segmentation
Fig. 10 U.S. DME market strategy framework
Fig. 11 U.S. DME market driver impact
Fig. 12 U.S. DME market restraint impact
Fig. 13 U.S. DME market porter’s five forces analysis
Fig. 14 U.S. DME market PESTEL analysis
Fig. 15 U.S. DME market: Product segment dashboard
Fig. 16 U.S. DME market: Product movement Analysis
Fig. 17 Personal mobility devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Wheelchairs estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Electric wheelchairs estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Manual wheelchairs estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Scooters market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Walkers & rollators market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Canes & crutches market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Door openers estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Other devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Bathroom safety device and medical furniture estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Commodes & toilets estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Mattress & bedding devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Blood sugar monitors estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Continuous passive motion (CPM) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Infusion pumps estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Nebulizers estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Oxygen equipment estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Continuous positive airway pressure (CPAP) estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Suction pumps estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Traction equipment estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Others equipment estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Insulin pumps estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Ostomy bags & accessories estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Wound care products estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Cardiology devices estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Vital signs monitors estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Respiratory supplies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Urinary supplies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Diabetic supplies estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Incontinence products estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Orthopedic braces & support system estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Muscle stimulators estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Others estimates and forecast, 2018 - 2030 (USD Million)